Floatz logo

IRON SUCCINATE (FE(O4C4H4))

Lymphoma

Peking UniversitySmall moleculePhase 4 / ApprovedDormant
B
56/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
65/ 100

Competitive context

243 Active assets in the Lymphoma cohort.

Asset / SponsorPhaseRating
VINBLASTINE
Intensity Therapeutics, Inc.
Phase 4BBB
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
The Lymphoma Academic Research Organisation
Phase 4BBB
BLEOMYCIN
Shandong Provincial Hospital
Phase 4BB
VINCRISTINE SULFATE
Inhye Ahn
Phase 3BB
Ifosfamide
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 3BB

View all 50 →

Same molecule, other indications

IRON SUCCINATE (FE(O4C4H4)) is also rated in:

Hematopoietic Stem Cell TransplantationDormant
BB
Indicative ·
65 / 100
View asset →
AnemiaDormant
BB
Indicative ·
65 / 100
View asset →
Phenylketonuria (PKU)Dormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →